Speech-Language Pathologists in Shreveport, LA Accepting Medicare

158 Speech-Language Pathologists found. Showing 81 - 100

Kristy Nicole Holmes, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 308 Stephenson St, Shreveport, LA 71104 Phone: 601-434-9338

Peyton Elizabeth Miller, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2530 Bert Kouns Industrial Loop Ste 148, Shreveport, LA 71118 Phone: 318-212-5336

Sandra L Hayes, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3730 Blair Dr, Lsuhsc-school Of Allied Health Professionals, Shreveport, LA 71103 Phone: 318-632-2030    Fax: 318-675-5666

Miss Deborah Sue Johnson, M.C.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 E Stoner Ave, Shreveport, LA 71101 Phone: 318-221-8411

Ms. Barbara King, MS.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5609 Cross Timbers Dr, Shreveport, LA 71129 Phone: 504-491-5474

Dana Williams, MCD/CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1950 E 70th St Ste A, Shreveport, LA 71105 Phone: 318-219-6064    Fax: 318-219-7928

Mrs. Gisele Proby Bryant Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6007 Financial Plz Ste 223, Shreveport, LA 71129 Phone: 318-393-3636    Fax: 318-688-7878

Kristen Ogden, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2226 Murphy St, Shreveport, LA 71103 Phone: 318-603-6800

Heather Ruth Nicholls, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 191 Bruce Ave, Shreveport, LA 71105 Phone: 318-218-1339

Rebecca Emery Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2226 Murphy St, Shreveport, LA 71103 Phone: 318-603-6300

Mrs. Taylor Ratcliff Alexander, M.C.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2226 Murphy Street, Shreveport, LA 71103 Phone: 318-603-6706

Mrs. Joycelyn W. Loyd, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 E Stoner Ave # 126, Shreveport, LA 71101 Phone: 318-424-6090

Laura Fielder Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10985 Harts Island Rd, Shreveport, LA 71115 Phone: 318-218-2189

Mrs. Yolanda Yvette Coleman-smith, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 650 Olive St, Shreveport, LA 71104 Phone: 318-537-4376

Ms. Janet May Filppula, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 360 College St, Shreveport, LA 71104 Phone: 318-525-2404

Mrs. Danae Day, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10108 Poydras St, Shreveport, LA 71106 Phone: 318-294-0133

Anesia Wesley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2522 E 70th St, Shreveport, LA 71105 Phone: 318-795-3388

Speech Solutions Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8870 Youree Dr, Suite 210, Shreveport, LA 71115 Phone: 318-798-2981

Speech Concepts, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8870 Youree Dr, Suite 216, Shreveport, LA 71115 Phone: 318-798-2981    Fax: 318-798-0447

Mrs. Kenya Leigh Soto, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 463 Ashley Ridge Blvd, Shreveport, LA 71106 Phone: 318-671-8772

News Archive

Phase III study demonstrates superiority of imiquimod cream 2.5% and 3.75% in treatment of AK

The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.

Turning off particular cytokines reduces Alzheimer's typical amyloid- deposits in mice

Alzheimer's disease is one of the most common causes of dementia. In Germany and Switzerland alone, around 1.5 million people are affected, and forecasts predict a doubling of the number of patients worldwide within the next 20 years. The accumulation of particular abnormal proteins, including amyloid- (Aβ) among others, in patients' brains plays a central role in this disease.

A global review of factors that influence current diagnosis delay in axSpA

The Axial Spondyloarthritis International Federation (ASIF) set out to coordinate a comprehensive evidence-based global review of the factors influencing the current diagnosis delay in axSpA, and to produce a definitive report that shines a light on these barriers, as well as providing a resource that can ultimately empower a range of international stakeholders to reduce this delay.

Researchers develop new blood test that can accurately diagnose concussions

Scientists from Children's Health Research Institute, a program of Lawson Health Research Institute, and Western University have developed a new blood test that identifies with greater than 90 per cent certainty whether or not an adolescent athlete has suffered a concussion.

Study finds increased use of antipsychotic medication among Medicaid-insured children

A new study from the University of Maryland found that use of antipsychotic drugs from 1997 to 2006 increased 7- to 12-fold in a Medicaid population of about 500,000 children ages two to 17.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3
• 4
• 5(current)
• 6
• 7
• 8